Seval Ay Ersoy
15PUBLICATIONS
59CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Mar 14, 2026
Impact of Peri-Immunotherapy Antibiotic Exposure on Survival Outcomes in Metastatic Renal Cell Carcinoma: A Real-World IMDC Risk-Stratified Analysis.Sila Oksuz, Oguzcan Kinikoglu, Ugur Ozkerim
|Feb 27, 2026
Association Between Body Mass Index and Clinical Outcomes of CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer: A Real-World Cohort Study.Seval Orman, Miray Aydoğan, Nisanur Sarıyar Busery
|Jan 28, 2026
Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes.Sedat Yildirim, Hatice Odabas, Seval Ay Ersoy
|Jan 10, 2026
Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide.Ugur Ozkerim, Oguzcan Kinikoglu, Deniz Isik
|Jan 10, 2026
Prognostic Impact of Tumor Size in Patients with Stage T3N1 Colon Cancer.Ezgi Turkoglu, Nisanur Sarıyar Busery, Sedat Yildirim
|Oct 29, 2025
The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study.Seval Orman, Miray Aydoğan, Oğuzcan Kınıkoğlu
Pageof 3
Frequent Collaborators
7 joint publications
Deniz Isık
7 joint publications
Nedim Turan
7 joint publications
Hatice Odabas
5 joint publications
Muhammed Mustafa Atcı
5 joint publications
Oguzcan Kınıkoglu
5 joint publications
Sedat Yıldırım
4 joint publications
Deniz Tataroglu Ozyukseler
4 joint publications
Ezgi Turkoglu
3 joint publications
Özgecan Dülgar
3 joint publications
Abdullah Sakin
